[1]虞夏慧 张连生.流行性感冒疫苗接种在心力衰竭中的研究进展[J].心血管病学进展,2022,(7):649-651.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
　YU Xiahui,ZHNG Liansheng.Influenza Vaccination in Heart Failure[J].Advances in Cardiovascular Diseases,2022,(7):649-651.[doi:10.16806/j.cnki.issn.1004-3934.2022.07.000]
点击复制

流行性感冒疫苗接种在心力衰竭中的研究进展()
分享到：

《心血管病学进展》[ISSN:51-1187/R/CN:1004-3934]

卷:
期数:
2022年7期
页码:
649-651
栏目:
综述
出版日期:
2022-07-25

文章信息/Info

Title:
Influenza Vaccination in Heart Failure
文章编号:
202203016
作者:
虞夏慧1 张连生1; 2
武汉科技大学医学院 鄂东医疗集团黄石市中心医院,湖北 黄石 435000;2. 武汉科技大学医学院,湖北 武汉 430000)
Author(s):
YU Xiahui;  ZHNG Liansheng
School of Medicine,Wuhan University of Science and technology,Huangshi Central Hospital,East Hubei Medical Group,Huangshi 435000,Hubei,China; 2. Medical College,Wuhan University of Science and Technology,Wuhan 430000,Hubei,China)
关键词:
心力衰竭; 流感病毒; 流感疫苗; 死亡率
Keywords:
Heart failure; Influenza virus; Influenza vaccine; Mortality rate
DOI:
10.16806/j.cnki.issn.1004-3934.2022.07.000
摘要:
心力衰竭（心衰）患者预后较差，即使接受最佳药物治疗，心衰患者1年死亡率平均为33%，5年生存率不足50%。心衰患者往往合并多器官功能不全，免疫力较低，极易感染流行性感冒（流感）病毒。研究证明慢性心衰患者在流感季节的总体住院率明显升高，并且流感季节的慢性心衰患者总体死亡率也显著升高，提示流感可能是增加心衰患者再入院率和死亡率的重要因素。接种流感疫苗已被证实可降低急性心衰的发生率，降低慢性心衰患者的病死率并预防快速性心律失常的发生。因此，现综述流感疫苗接种在心衰中的研究进展，旨在为临床上改善心衰患者的预后提供理论依据。
Abstract:
Patients with heart failure(HF) have a poor prognosis. The 1-year mortality rate of HF patients is 33% on average,and the 5-year survival rate is less than 50%,even after receiving optimal drug therapy. HF patients are often complicated with multiple organ dysfunction and low immunity,and are highly susceptible to influenza virus. The study proved that the overall hospitalization rate of patients with chronic HF increased significantly during the influenza season,and the overall mortality rate of patients with chronic HF also increased significantly during the influenza season,suggesting that influenza may be an important factor in increasing the readmission rate and mortality rate of patients with HF. Influenza vaccination has been shown to reduce the incidence rate of acute HF,reduce mortality rate in patients with chronic HF,and prevent tachyarrhythmia. Therefore,this article reviews the research progress of influenza vaccination in HF,in order to provide theoretical basis for improving the prognosis of patients with HF

参考文献/References:

[1] Emmons-Bell S,Johnson C,Roth G. Prevalence,incidence and survival of heart failure:a systematic review[J]. Heart,2022,Jan 18:heartjnl-2021-320131.?DOI: 10.1136/heartjnl-2021-320131. Epub ahead of print.
[2] 殷鹏,齐金蕾,刘韫宁,等. 2005～2017年中国疾病负担研究报告[J]. 中国循环杂志,2019,34(12):1145-1154.
[3] Zhang Y,Bauersachs J,Langer HF. Immune mechanisms in heart failure[J]. Eur J Heart Fail,2017,19(11):1379-1389.
[4] Bhugra P,Grandhi GR,Mszar R,et al. Determinants of influenza vaccine uptake in patients with cardiovascular disease and strategies for improvement[J]. J Am Heart Assoc,2021,10(15):e019671.
[5] Behrouzi B,Udell JA. Moving the needle on atherosclerotic cardiovascular disease and heart failure with influenza vaccination[J]. Curr Atheroscler Rep,2021,23(12):78.
[6] Mefford MT,Liu R,Bruxvoort K,et al. Influenza vaccination and mortality among adults with heart failure in an integrated healthcare delivery system,2009–2018[J]. J Gen Intern Med,2021,Aug 11. DOI: 10.1007/s11606-021-07068-x. Epub ahead of print.
[7] Peretz A,Azrad M,Blum A. Influenza virus and atherosclerosis[J]. QJM,2019,112(10):749-755.
[8] Somes MP,Turner RM,Dwyer LJ,et al. Estimating the annual attack rate of seasonal influenza among unvaccinated individuals:a systematic review and meta-analysis[J]. Vaccine,2018,36(23):3199-3207.
[9] Kwong JC,Schwartz KL,Campitelli MA,et al. Acute myocardial infarction after laboratory-confirmed influenza infection[J]. N Engl J Med,2018,378(4):345-353.
[10] Sandoval C,Walter SD,Krueger P,et al. Comparing estimates of influenza-associated hospitalization and death among adults with congestive heart failure based on how influenza season is defined[J]. BMC Public Health,2008,8:59.
[11] Panhwar MS,Kalra A,Gupta T,et al. Effect of influenza on outcomes in patients with heart failure[J]. JACC Heart Fail,2019,7(2):112-117.
[12] Li R,Stewart B,Mcneil MM,et al. Post licensure surveillance of influenza vaccines in the Vaccine Safety Datalink in the 2013-2014 and 2014-2015 seasons[J]. Pharmacoepidemiol Drug Saf,2016,25(8):928-934.
[13] Vardeny O,Kim K,Udell JA,et al. Effect of high-dose trivalent vs standard-dose quadrivalent influenza vaccine on mortality or cardiopulmonary hospitalization in patients with high-risk cardiovascular disease[J]. JAMA,2021,325(1):39.
[14] Mcdonagh TA,Metra M,Adamo M,et al. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure[J]. Eur Heart J,2021,42(36):3599-3726.
[15] Kopel E,Klempfner R,Goldenberg I. Influenza vaccine and survival in acute heart failure[J]. Eur J Heart Fail,2014,16(3):264-270.
[16] Seo YB,Choi WS,Baek JH,et al. Effectiveness of the influenza vaccine at preventing hospitalization due to acute exacerbation of cardiopulmonary disease in Korea from 2011 to 2012[J]. Hum Vaccin Immunother,2014,10(2):423-427.
[17] Mohseni H,Kiran A,Khorshidi R,et al. Influenza vaccination and risk of hospitalization in patients with heart failure:a self-controlled case series study[J]. Eur Heart J,2017,38(5):326-333.?
[18] Gotsman I,Shuvy M,Tahiroglu I,et al. Influenza vaccination and outcome in heart failure[J]. Am J Cardiol,2020,128:134-139.
[19] Fukuta H,Goto T,Wakami K,et al. The effect of influenza vaccination on mortality and hospitalization in patients with heart failure:a systematic review and meta-analysis[J]. Heart Fail Rev,2019,24(1):109-114.
[20] Rodrigues BS,David C,Costa J,et al. Influenza vaccination in patients with heart failure:a systematic review and meta-analysis of observational studies[J]. Heart,2020,106(5):350-357.
[21] Modin D,J?rgensen ME,Gislason G,et al. Influenza vaccine in heart failure[J]. Circulation,2019,139(5):575-586.
[22] Chang TY,Chao TF,Liu CJ,et al. The association between influenza infection,vaccination,and atrial fibrillation:a nationwide case-control study[J]. Heart Rhythm,2016,13(6):1189-1194.
[23] Singh SM,de Souza RJ,Kumareswaran R. Increased defibrillator therapies during influenza season in patients without influenza vaccines[J]. J Arrhythm,2015,31(4):210-214.

相似文献/References:

[1]丁娟,刘地川.心力衰竭与线粒体功能障碍的研究进展[J].心血管病学进展,2016,(1):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
　DING Juan,LIU Dichuan.Research Progress of Heart Failure and Mitochondrial Dysfunction[J].Advances in Cardiovascular Diseases,2016,(7):84.[doi:10.16806/j.cnki.issn.1004-3934.2016.01.022]
[2]罗秀林,综述,张烁,等.肾动脉去交感神经术治疗心力衰竭——希望还是炒作[J].心血管病学进展,2016,(3):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
　LUO Xiulin,ZHANG Shuo.Renal Sympathetic Denervation for Heart Failure—Hopes or Hypes[J].Advances in Cardiovascular Diseases,2016,(7):268.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.013]
[3]查凤艳,综述,覃数,等.心源性恶病质发病机制的研究进展[J].心血管病学进展,2016,(3):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
　ZHA Fengyan,QIN Shu.Advances in Pathogenesis of Cardiac Cachexia[J].Advances in Cardiovascular Diseases,2016,(7):282.[doi:10.16806/j.cnki.issn.1004-3934.2016.03.017]
[4]李慧,综述,齐国先,等.老年射血分数保留的心功能不全研究进展[J].心血管病学进展,2016,(4):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
　LI Hui,QI Guoxian.Research Progress of Heart Failure with Preserved Ejection Fraction in Elderly People[J].Advances in Cardiovascular Diseases,2016,(7):354.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.007]
[5]亢玉,综述,张庆,等.二尖瓣瓣叶在功能性二尖瓣反流发生机制中的角色[J].心血管病学进展,2016,(4):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
　KANG Yu,ZHANG Qing.Role of Mitral Leaflets in Pathogenesis of Functional Mitral Regurgitation[J].Advances in Cardiovascular Diseases,2016,(7):376.[doi:10.16806/j.cnki.issn.1004-3934.2016.04.013]
[6]史秀莉,张庆,喻鹏铭.心力衰竭患者运动训练方式及其疗效的研究进展[J].心血管病学进展,2015,(5):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
　SHI Xiuli,ZHANG Qing,YU Pengming.Exercise Training Modalities and Their Treatment Effects on Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2015,(7):535.[doi:10.3969/j.issn.1004-3934.2015.05.003]
[7]熊卓超,陈康玉,严激.无创血流动力学评价在心力衰竭中的应用进展[J].心血管病学进展,2019,(6):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
　XIONG Zhuochao,CHEN Kangyu,YAN Ji.Application Progress of Noninvasive Hemodynamic Evaluation in Heart Failure[J].Advances in Cardiovascular Diseases,2019,(7):923.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.021]
[8]高薇 陈伟.铁过载性心肌病[J].心血管病学进展,2019,(5):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
　GAO WeiCHEN Wei.Iron Overload Cardiomyopathy[J].Advances in Cardiovascular Diseases,2019,(7):680.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.006]
[9]何燕 刘育.C型利钠肽与心力衰竭[J].心血管病学进展,2019,(5):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
　HE Yan,LIU Yu.C-type Natriuretic Peptide and Heart Failure[J].Advances in Cardiovascular Diseases,2019,(7):745.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.020]
[10]吴彤 高东来.心房颤动合并心力衰竭的射频消融治疗[J].心血管病学进展,2019,(5):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]
　WU TongGAO Donglai.Catheter Ablation of Atrial Fibrillation in Patients with Heart Failure[J].Advances in Cardiovascular Diseases,2019,(7):757.[doi:10.16806/j.cnki.issn.1004-3934.2019.05.023]

更新日期/Last Update: 2022-08-22